Search General Info
Search Education
Search Partnering Companies
![CEO 2023 Logo](/sites/default/files/2022-08/264423_BIO_22_CEO_Logo-V.png)
ENB Therapeutics is a clinical stage privately held company developing therapies to treat drug resistant cancers by reprogramming the tumor microenvironment. Our lead product, ENB-003, is a First-in-Class, small molecule, selective endothelin B receptor inhibitor that overcomes immunotherapy resistance across multiple cancer indications in preclinical studies. ENB-003 dramatically enhances CAR-T efficacy in a triple negative breast cancer model, eradicating most tumors within 3 weeks. In our ongoing international Phase 1 trial in collaboration with Merck, ENB-003, in combination with pembrolizumab, is well tolerated and demonstrates encouraging efficacy signals in drug refractory, heavily pre-treated pancreatic cancer, ovarian cancer and melanoma. ENB-003 is the key to unlocking new therapeutic markets in indications that do not respond to immunotherapies such as anti-PD1/PDL1, CTLA-4, CAR-T and cancer vaccines. We are currently raising a Series B round to support our Phase 2 trial.
![](/sites/default/files/hubb_images/6588/attachments/%2520-%2520f1_ENB_20Therapeutics_c6ddd5d3.jpg)
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2015
Main Therapeutic Focus:
Oncology
Lead Product in Development:
ENB-003
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
![photo](/sites/default/files/hubb_images/6588/photos/user1.Jamal.bcd1dd82.jpg)
BIO DOUBLE HELIX SPONSORS
![Sanofi logo](/sites/default/files/2022-05/Sanofi_Color_jpg_Double%20Helix.jpg)
![Eli Lilly and Company](/sites/default/files/2019-09/Eli%20Lilly%20and%20Company.png)
![Amgen logo](/sites/default/files/2022-05/Amgen_Color_png_Double%20Helix.png)
![Genentech logo](/sites/default/files/2022-05/Genentech_Color_png_Double%20Helix.png)
![Merck_logo_2022](/sites/default/files/2022-10/Merck_Color_.png)
![Avantor](/sites/default/files/2021-06/Avantor-BIO-DH-578.png)
![GSK logo](/sites/default/files/2023-04/gsk_color_png.png)
BIO HELIX SPONSORS
![Johnson and Johnson](/sites/default/files/2021-06/Johnson-Johnson-BIO-DH-578.png)
![Takeda logo](/sites/default/files/2022-05/Takeda_Color_jpg_Premier.jpg)
![Travere logo](/sites/default/files/2022-05/Travere_Color_png_Helix%20large.png)
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved